Richard J. Barry

Richard J. Barry

President and Chief Executive OfficeratFilana Therapeutics· In proxies 2023–2025

Pay in FY2025-91% from the year before · Filana Therapeutics stock -16.1% the same year

Richard J. Barry was paid $1.5M in FY2025 (Dec), down 91%. Filana Therapeutics stock fell 16.1% that year.

Pay$100 in the stock at the end of FY22 → $7
Pay is from the Summary Compensation Table of each Filana Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Filana TherapeuticsPublic company · 3 yr
    • President and Chief Executive Officer2023 – Present · 3 yrStock in role -98%
  2. Sarepta Therapeutics, Inc.Public company · 11 yr
    • Director2015 – Present · 11 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?